Preparation and Characterization of Immediate and Extended Release Levetiracetam Coated Pellets using Extrusion-Spheronization Technique Immediate/ Extended Release Levetiracetam Coated Pellets
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 January 2025
,
Page 217-228
https://doi.org/10.22037/ijps.v21i1.46300
Abstract
Levetiracetam (LEV), an antiepileptic compound with a bitter taste, is used to treat different types of epilepsy in both adult and pediatric patients. While a wide range of doses is required for various age groups, some patients have difficulties in swallowing large solid dosage forms. Therefore, this study aimed to prepare and evaluate taste-masked LEV coated pellets with immediate and extended release behavior for flexible drug dosing, ease of swallowing, and higher patient compliance. LEV core pellets were prepared using the extrusion-spheronization technique and evaluated in terms of physical properties. In the next step, two coating processes were performed separately on the optimal formulation using different polymers to prepare a taste-masked immediate release formulation and to achieve an extended release product. Further experiments were conducted on the coated pellets, such as dissolution, morphology, and taste-masking evaluations.
Based on the results, optimum LEV-loaded core pellets with suitable physical properties were prepared with the size, aspect ratio, and projection sphericity of 1.18 mm, 1.08, and 0.92, respectively. Coating the pellets with Eudragit E, while having appropriate dissolution in an acidic medium, provided an acceptable taste-masking, confirmed by in-vitro and in-vivo analysis. Extended release LEV pellets were obtained by coating the core pellets with a proper Eudragit RL/RS combination. Desirable dissolution profiles were achieved using 30 % coating polymer on the surface of the pellets. In addition to the advantages of taste-masked immediate and extended release LEV pellet formulations, it should be pointed out that preparing these multi-particulate systems by coating similar core pellets with various polymers can be cost-effective from the production point of view.
- Extended release
- Extrusion–spheronization
- Levetiracetam
- Pellets
- Taste-masking
How to Cite
References
Contreras-García, I.J., et al., Levetiracetam mechanisms of action: from molecules to systems. Pharmaceuticals, 2022. 15(4): 475-516.
Liu, Y., et al., Bioequivalence and Safety of Levetiracetam Granules and Oral Solution: A Randomized, Single‐Dose, 2‐Period Crossover Study in Healthy Chinese Volunteers Under a Fasting Condition. Clin. Pharmacol. Drug Dev., 2022. 11(3): 372-378.
Patsalos, P.N., Clinical pharmacokinetics of levetiracetam. Clin. Pharmacokinet., 2004. 43(11): 707-724.
Yamamoto, Y., et al., Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy. Brain Dev., 2023. 45(5): 285-292.
Chappell, K., et al., Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy. J. Crit. Care, 2021. 61: 216-220.
Schiele, J.T., et al., Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur. J. Clin. Pharm., 2013. 69(4): 937-948.
Nasiri, M.I., et al., Investigation on release of highly water soluble drug from matrix-coated pellets prepared by extrusion–spheronization technique. J. Coat. Technol. Res., 2016. 13(2): 333-344.
Agrawal, S., et al., Quality aspects in the development of pelletized dosage forms. Heliyon, 2022. 8: e08956.
Siebel, F. and Kleinebudde P., Croscarmellose sodium as pelletization aid in extrusion-spheronization. AAPS PharmSciTech, 2024. 25(6): 147.
Pápay, Z.E., et al., Development of oral site-specific pellets containing flavonoid extract with antioxidant activity. Eur. J. Pharm. Sci., 2016. 95: 161-169.
Chen, T., et al., Tablets of multi-unit pellet system for controlled drug delivery. J. Control. Rel., 2017. 262: 222-231.
Mistry, P., Batchelor H., and S.U. project, Evidence of acceptability of oral paediatric medicines: a review. J. Pharm. Pharmacol., 2017. 69(4): 361-376.
Thi, T.H.H., et al., Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use. Int. J. Pharm., 2015. 496(2): 842-849.
Trivedi, N.R., et al., Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit. Rev. Ther. Drug Carr. Syst., 2007. 24(1): 1-40.
Muley, S., Nandgude T., and Poddar S., Extrusion–spheronization a promising pelletization technique: In-depth review. Asian J. Pharm. Sci., 2016. 11(6): 684-699.
Lin, S. Y., Chen K. S., and Run-Chu L., Organic esters of plasticizers affecting the water absorption, adhesive property, glass transition temperature and plasticizer permanence of Eudragit acrylic films. J. Control. Rel., 2000. 68(3): 343-350.
Qazi, F., et al., QbD based Eudragit coated meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-Fluorescence detection method. Sci. Rep., 2020. 10(1): 14765.
Lam, M., Ghafourian T., and Nokhodchi A., Liqui-pellet: the emerging next-generation oral dosage form which stems from liquisolid concept in combination with pelletization technology. AAPS Pharmscitech, 2019. 20: 1-16.
Dukić-Ott, A., et al., Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Eur. J. Pharm. Biopharm., 2007. 67(3): 715-724.
Abdalla, A. and Mäder K., Preparation and characterization of a self-emulsifying pellet formulation. Eur. J. Pharm. Biopharm., 2007. 66(2): 220-226.
Sinha, V., Agrawal M., and Kumria R., Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Curr. Drug Deliv., 2005. 2(1): 1-8.
USP, United States Pharmacopeia and the National Formulary. 40th edition United States Pharmacopeia Convention. 2017.
Jadhav, N., et al., Extrusion-spheronization of talc using microcrystalline cellulose as a pellet aid: Part I. J. Pharm. Innov., 2014. 9(4): 321-330.
Qazi, F., et al., Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent—Meclizine HCl. Lipids Health Dis., 2017. 16(1): 75.
Pawar, H.A. and Joshi P.R., Development and evaluation of taste masked granular formulation of satranidazole by melt granulation technique. J. Pharm., 2014. 789676.
Bora, D., Borude P., and Bhise K., Taste masking by spray-drying technique. Aaps Pharmscitech, 2008. 9(4): 1159-1164.
Samprasit, W., et al., Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins. Drug Development and Industrial Pharmacy, 2015. 41(6): 1006-1016.
Sinha, V., Agrawal M., and Kumria R., Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Current Drug Del, 2005. 2(1): 1-8.
Xia, Y., et al., Approaches to developing fast release pellets via wet extrusion-spheronization. Pharm. Dev. Tech., 2018. 23(5): 432-441.
Liew, C.V., et al., Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose. Pharm. Res., 2005. 22(8): 1387-1388.
Boutell, S., et al., The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization. Int J Pharm, 2002. 238(1-2): 61-76.
Gurram, R.K., Gandra S., and Shastri N.R., Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools. Eur J Pharm Sci, 2016. 84: 146-156.
Lavanya, K., Senthil V., and Rathi V., Pelletization technology: a quick review. Int. J. Pharm. Sci. Res., 2011. 2(6): 1337.
Petruševska, M., et al., Biowaiver monographs for immediate release solid oral dosage forms: levetiracetam. J Pharm Sci, 2015. 104(9): 2676-2687.
Drašković, M., et al., In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drug Dev Ind Pharm, 2017. 43(5): 723-731.
Nasiri, M.I., et al., Formulation development and characterization of highly water-soluble drug-loaded extended-release pellets prepared by extrusion–spheronization technique. J. Coat. Technol. Res., 2019. 16(5): 1351-1365.
Bolourchian, N. and Bahjat M., Design and In Vitro Evaluation of Eudragit-Based Extended Release Diltiazem Microspheres for Once-and Twice-Daily Administration: The Effect of Coating on Drug Release Behavior. Turk. J. Pharm. Sci., 2019. 16(3): 340-347.
Simšič, T., Planinšek O., and Baumgartner A., Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs. Acta Pharm, 2024. 74(2 (Special Issue)): 177-199.
- Abstract Viewed: 324 times
- IJPS_Volume21_Issue1_Pages217-228 Downloaded: 281 times